AstraZeneca PLC is 179.0x more valuable than Nanobiotix S.A. by market capitalization ($286.27 B vs $1.60 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NBTX | AZN |
|---|---|---|
| Market cap | $1.60 B | $286.27 B |
| US-listed rank | #2275 | #45 |
| SEC filings | 295 | 1,004 |
AstraZeneca PLC is 179.0x more valuable than Nanobiotix S.A. by market capitalization ($286.27 B vs $1.60 B).
Full pages: Nanobiotix S.A. and AstraZeneca PLC, or browse the full rankings.